Showing results (221-230 of 395) with videos related to
Sort By:
Pageof 40
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95, Russell L Basser, Anne O'Neill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP systemClifford A Hudis, William E Barlow, Joseph P Costantino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatmentMarco Colleoni, Giuseppe Viale, David Zahrieh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA TrialMitch Dowsett, Marion Procter, Worta McCaskill-Stevens, et al.JAMA Oncology|October 6, 2022
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and MisinterpretationsFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.British Journal of Cancer|September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)J Bernhard, C Hürny, A S Coates, et al.Breast (Edinburgh, Scotland)|October 8, 2013
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trialsMeredith M Regan, Olivia Pagani, Gini F Fleming, et al.Lancet (London, England)|June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?S Aebi, S Gelber, M Castiglione-Gertsch, et al.Pageof 40